Cocaine withdrawal reduces group I mGluR-mediated long-term potentiation via decreased GABAergic transmission in the amygdala. 2011

Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
Department of Pharmacology and Toxicology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.

Cocaine relapse can occur when cocaine-associated environmental cues induce craving. Conditioned place preference (CPP) is a behavioral paradigm modeling the association between cocaine exposure and environmental cues. The amygdala is involved in cocaine cue associations with the basolateral amygdala (BLA) and central amygdala (CeA) acting differentially in cue-induced relapse. Activation of metabotropic glutamate receptors induces synaptic plasticity, the mechanism of which is thought to underlie learning, memory and drug-cue associations. The goal of this study was to examine the neural alterations in responses to group I metabotropic glutamate receptor (mGluR) agonists in the BLA to lateral capsula of CeA (BLA-CeLc) pathway in slices from rats exposed to cocaine-CPP conditioning and withdrawn for 14 days. mGluR1, but not mGluR5, agonist-induced long-term potentiation (mGluR1-LTP) in the BLA-CeLc pathway was reduced in rats withdrawal from cocaine for 2 and 14 days, and exhibited an altered concentration response to picrotoxin. Cocaine withdrawal also reduced γ-aminobutyric acid (GABA)ergic synaptic inhibition in CeLc neurons. Blocking cannabinoid receptor 1 (CB(1) ) reduced mGluR1-LTP in the saline-treated but not cocaine-withdrawn group. Response to CB(1) but not CB(2) agonist was altered after cocaine. Additionally, increasing endocannabinoid (eCB) levels abolished mGluR1-LTP in the saline but not cocaine-withdrawn group. However, CB(1) and CB(2) protein levels were increased in the amygdala of cocaine-withdrawn rats while mGluR1 and mGluR5 remained unchanged. These data suggested that the mechanisms underlying the diminished mGluR1-LTP in cocaine-withdrawn rats involve an altered GABAergic synaptic inhibition mediated by modulation of downstream eCB signaling. These changes may ultimately result in potentiated responses to environmental cues that would bias behavior toward drug-seeking.

UI MeSH Term Description Entries
D008297 Male Males
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D010852 Picrotoxin A mixture of PICROTOXININ and PICROTIN that is a noncompetitive antagonist at GABA-A receptors acting as a convulsant. Picrotoxin blocks the GAMMA-AMINOBUTYRIC ACID-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates. 3,6-Methano-8H-1,5,7-trioxacyclopenta(ij)cycloprop(a)azulene-4,8(3H)-dione, hexahydro-2a-hydroxy-9-(1-hydroxy-1-methylethyl)-8b-methyl-, (1aR-(1aalpha,2abeta,3beta,6beta,6abeta,8aS*,8bbeta,9S*))-, compd. with (1aR-(1aalpha,2abeta,3beta,6beta,6abeta,8,Cocculin
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D003213 Conditioning, Psychological Simple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response. Conditioning, Psychology,Psychological Conditioning,Social Learning Theory,Social Learning Theories,Theory, Social Learning
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D000679 Amygdala Almond-shaped group of basal nuclei anterior to the INFERIOR HORN OF THE LATERAL VENTRICLE of the TEMPORAL LOBE. The amygdala is part of the limbic system. Amygdaloid Body,Amygdaloid Nuclear Complex,Amygdaloid Nucleus,Archistriatum,Corpus Amygdaloideum,Intercalated Amygdaloid Nuclei,Massa Intercalata,Nucleus Amygdalae,Amygdalae, Nucleus,Amygdaloid Bodies,Amygdaloid Nuclear Complices,Amygdaloid Nuclei, Intercalated,Amygdaloid Nucleus, Intercalated,Amygdaloideum, Corpus,Amygdaloideums, Corpus,Archistriatums,Complex, Amygdaloid Nuclear,Complices, Amygdaloid Nuclear,Corpus Amygdaloideums,Intercalata, Massa,Intercalatas, Massa,Intercalated Amygdaloid Nucleus,Massa Intercalatas,Nuclear Complex, Amygdaloid,Nuclear Complices, Amygdaloid,Nuclei, Intercalated Amygdaloid,Nucleus, Amygdaloid,Nucleus, Intercalated Amygdaloid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
April 2011, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
March 2010, The European journal of neuroscience,
Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
March 2009, Journal of neurophysiology,
Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
September 2006, The European journal of neuroscience,
Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
July 1999, The Journal of physiology,
Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
August 1999, Journal of neurophysiology,
Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
January 1990, Synapse (New York, N.Y.),
Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
January 2007, Journal of neurophysiology,
Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
January 2016, Neural plasticity,
Kady Schmidt, and Balaji Krishnan, and Yan Xia, and Anyang Sun, and Luis Orozco-Cabal, and Sebastian Pollandt, and Marjorie Centeno, and Kathy Genzer, and Joel P Gallagher, and Patricia Shinnick-Gallagher, and Jie Liu
May 2002, Brain research,
Copied contents to your clipboard!